Charlotte Rigaud

765 total citations
30 papers, 297 citations indexed

About

Charlotte Rigaud is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Charlotte Rigaud has authored 30 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Charlotte Rigaud's work include Lymphoma Diagnosis and Treatment (19 papers), Acute Lymphoblastic Leukemia research (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Charlotte Rigaud is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Acute Lymphoblastic Leukemia research (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Charlotte Rigaud collaborates with scholars based in France, Netherlands and Italy. Charlotte Rigaud's co-authors include Alice Goldenberg, Michèle Mathieu‐Dramard, Sylvie Di Filippo, Géraldine Viot, Jean Donadieu, Chris Ottolenghi, A. Chabli, Philippe Charron, Anne-Sophie Lèbre and Blandine Beaupain and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Charlotte Rigaud

25 papers receiving 292 citations

Peers

Charlotte Rigaud
Pierluigi Marradi Italy
Halil Gürhan Karabulut Türkiye
Juan Tao China
Virginie Grouthier France
G. Mortimer Ireland
Joe Matsuoka Japan
Arian Pano United States
Takahisa Kobayashi Japan
Haibo Zhao China
Pierluigi Marradi Italy
Charlotte Rigaud
Citations per year, relative to Charlotte Rigaud Charlotte Rigaud (= 1×) peers Pierluigi Marradi

Countries citing papers authored by Charlotte Rigaud

Since Specialization
Citations

This map shows the geographic impact of Charlotte Rigaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Rigaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Rigaud more than expected).

Fields of papers citing papers by Charlotte Rigaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Rigaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Rigaud. The network helps show where Charlotte Rigaud may publish in the future.

Co-authorship network of co-authors of Charlotte Rigaud

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Rigaud. A scholar is included among the top collaborators of Charlotte Rigaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Rigaud. Charlotte Rigaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bastard, Paul, Nathalie Cozic, Régis Brion, et al.. (2024). Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience. Pediatric Blood & Cancer. 71(7). e31029–e31029. 1 indexed citations
2.
Aladjidi, Nathalie, Audrey Contet, Jean‐Hugues Dalle, et al.. (2024). Outcome of childhood ALK‐positive anaplastic large cell lymphoma relapses: Real‐life experience of the French Society of Pediatric Oncology (SFCE) cohort of 75 French children. Pediatric Blood & Cancer. 72(1). e31397–e31397. 1 indexed citations
3.
Guerrini‐Rousseau, Léa, Richard Gallon, Marta Pineda, et al.. (2024). Report of the sixth meeting of the European Consortium ‘Care for CMMRD’ (C4CMMRD), Paris, France, November 16th 2022. Familial Cancer. 23(4). 447–457. 3 indexed citations
4.
Simonin, Mathieu, Sabah Boudjemaa, Charlotte Rigaud, et al.. (2024). R-CVP in Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children. Blood. 144(Supplement 1). 6349–6349.
5.
Rigaud, Charlotte, et al.. (2023). Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents. Best Practice & Research Clinical Haematology. 36(1). 101444–101444. 8 indexed citations
6.
Dourthe, Marie-Émilie, Mathieu Simonin, Charlotte Rigaud, et al.. (2023). Recommandations de la SFCE pour la prise en charge du lymphome de Hodgkin nodulaire à prédominance lymphocytaire de l’enfant et de l’adolescent. Bulletin du Cancer. 110(9). 968–977.
7.
Lueza, B., Anne Aupérin, Charlotte Rigaud, et al.. (2023). Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin’s lymphoma. The European Journal of Health Economics. 25(2). 307–317. 2 indexed citations
8.
Vasseur, Damien, Samuel Abbou, Ludovic Lacroix, et al.. (2023). Circulating Tumor DNA (ctDNA) for Plasma Genotyping and Disease Monitoring in ALK-Positive Anaplastic Lymphoma (ALK+ALCL): A Proof of Concept Study. Blood. 142(Supplement 1). 4375–4375.
9.
Dourthe, Marie-Émilie, Anne Aupérin, Jacques Bosq, et al.. (2022). Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study. Haematologica. 107(9). 2173–2182. 12 indexed citations
10.
Harker‐Murray, Paul, Christine Mauz‐Körholz, Thierry Leblanc, et al.. (2022). Nivolumab, Brentuximab Vedotin, +/- Bendamustine For R/R Hodgkin Lymphoma in Children, Adolescents, and Young Adults. Blood. 141(17). 2075–2084. 17 indexed citations
11.
12.
Trinquand, Amélie, Adriana Pleșa, Nathalie Aladjidi, et al.. (2021). Toward Pediatric T Lymphoblastic Lymphoma Stratification Based on Minimal Disseminated Disease and NOTCH1/FBXW7 Status. HemaSphere. 5(10). e641–e641. 5 indexed citations
13.
Rigaud, Charlotte, Rachid Abbas, David Grand, et al.. (2021). Should treatment of ALK‐positive anaplastic large cell lymphoma be stratified according to minimal residual disease?. Pediatric Blood & Cancer. 68(6). e28982–e28982. 8 indexed citations
14.
Sapuppo, Giulia, Dana M. Hartl, Brice Fresneau, et al.. (2021). Differentiated Thyroid Cancer in Children and Adolescents: Long Term Outcome and Risk Factors for Persistent Disease. Cancers. 13(15). 3732–3732. 19 indexed citations
15.
Pacquement, Hélène, Charlotte Rigaud, Mathieu Simonin, et al.. (2020). Maternal exposure to pesticides and risk of childhood lymphoma in France: A pooled analysis of the ESCALE and ESTELLE studies (SFCE). Cancer Epidemiology. 68. 101797–101797. 6 indexed citations
16.
Rigaud, Charlotte, Anne Aupérin, Anne Jourdain, et al.. (2019). Outcome of relapse in children and adolescents with B‐cell non‐Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study. Pediatric Blood & Cancer. 66(9). e27873–e27873. 21 indexed citations
17.
Damy, Thibaud, Arnaud Jaccard, Aziz Guellich, et al.. (2016). Identification of prognostic markers in transthyretin and AL cardiac amyloidosis*. Amyloid. 23(3). 194–202. 52 indexed citations
18.
Rigaud, Charlotte, Anne-Sophie Lèbre, Renaud Touraine, et al.. (2013). Natural history of Barth syndrome: a national cohort study of 22 patients. Orphanet Journal of Rare Diseases. 8(1). 70–70. 97 indexed citations
19.
Demange, Liliane, et al.. (1994). Chronology of combined chemotherapy (5FU) and radiotherapy. I. In vitro study.. PubMed. 13(6A). 2177–6. 12 indexed citations
20.
Bogomoletz, Wladimir V., et al.. (1987). Hétérotopie muqueuse gastrique de l'oesophage cervical chez l'adulte: curiosité endoscopique?. Gastroentérologie Clinique et Biologique. 11(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierluigi Marradi Breakdown of academic impact, for papers by Halil Gürhan Karabulut Breakdown of academic impact, for papers by Juan Tao Breakdown of academic impact, for papers by Virginie Grouthier Breakdown of academic impact, for papers by G. Mortimer Breakdown of academic impact, for papers by Joe Matsuoka Breakdown of academic impact, for papers by Arian Pano Breakdown of academic impact, for papers by Takahisa Kobayashi Breakdown of academic impact, for papers by Haibo Zhao
Rankless by CCL
2026